Sarcomatoid carcinoma of the lung epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Trushatank (talk | contribs) (→Region) |
Trushatank (talk | contribs) |
||
| Line 34: | Line 34: | ||
===Region=== | ===Region=== | ||
*Geographical location has no effect on the epidemiology of sarcomatoid carcinoma of the lung. | *Geographical location has no effect on the epidemiology of sarcomatoid carcinoma of the lung. | ||
===Developing Countries=== | ===Developing Countries=== | ||
Revision as of 17:32, 31 December 2018
|
Sarcomatoid Carcinoma of the Lung Microchapters |
|
Differentiating Sarcomatoid Carcinoma of the Lung from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sarcomatoid carcinoma of the lung epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Sarcomatoid carcinoma of the lung epidemiology and demographics |
|
FDA on Sarcomatoid carcinoma of the lung epidemiology and demographics |
|
CDC on Sarcomatoid carcinoma of the lung epidemiology and demographics |
|
Sarcomatoid carcinoma of the lung epidemiology and demographics in the news |
|
Blogs on Sarcomatoid carcinoma of the lung epidemiology and demographics |
|
Directions to Hospitals Treating Sarcomatoid carcinoma of the lung |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The prevalence of sarcomatoid carcinoma of the lung is approximately 0.4 cases per 100,000 individuals worldwide.[1]
- Sarcomatoid carcinoma comprises of 0.3% to 1.3% of total lung malignancies.[2]
- The overall prevalence of sarcomatoid carcinoma of the lung is 0.1% to 0.4% of all non-small cell lung malignancies.[3]
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Sarcomatoid carcinoma of the lung is more commonly diagnosed among patients aged 65 to 75 years old.[4]
- Sarcomatoid carcinoma of the lung is more commonly observed among elderly patients and adults.
- Biphasic blastoma subtype is an exception and an average age of 35 years old patients being more commonly diagnosed
Race
- There is no racial predilection to sarcomatoid carcinoma of the lung.
Gender
- Males are more commonly affected with sarcomatoid carcinoma of the lung than females.[5][6]
- The male to female ratio is 4:1.[4]
- Biphasic blastoma subtype is an exception, that affects men and women equally.
Region
- Geographical location has no effect on the epidemiology of sarcomatoid carcinoma of the lung.
Developing Countries
References
- ↑ Franks TJ, Galvin JR (2010). "Sarcomatoid carcinoma of the lung: histologic criteria and common lesions in the differential diagnosis". Arch. Pathol. Lab. Med. 134 (1): 49–54. doi:10.1043/2008-0547-RAR.1. PMID 20073605.
- ↑ Travis WD; Brambilla E; Müller-Hermelink K; Harris C; Kleihues C; Sobin P. https://www.iarc.fr/wp-content/uploads/2018/07/BB10.pdf
|chapterurl=missing title (help) (PDF). World Health Organization Classification of Tumours; Pathology and genetics of tumors of the lung, pleura, thymus, and heart. IARC Press. pp. 53–58. ISBN ISBN 92 832 2418 3 Check|isbn=value: invalid character (help). - ↑ Brambilla, E.; Travis, W.D.; Colby, T.V.; Corrin, B.; Shimosato, Y. (2001). "The new World Health Organization classification of lung tumours". European Respiratory Journal. 18 (6): 1059–1068. doi:10.1183/09031936.01.00275301. ISSN 0903-1936.
- ↑ 4.0 4.1 Ouziane, Imane; Boutayeb, Saber; Mrabti, Hind; Lalya, Issam; Rimani, Mouna; Errihani, Hassan (2014). "Sarcomatoid carcinoma of the lung: A model of resistance of chemotherapy". North American Journal of Medical Sciences. 6 (7): 342. doi:10.4103/1947-2714.136920. ISSN 1947-2714.
- ↑ Petrov, D.B; Vlassov, V.I; Kalaydjiev, G.T; Plochev, M.A; Obretenov, E.D; Stanoev, V.I; Danon, S.E (2003). "Primary pulmonary sarcomas and carcinosarcomas – postoperative results and comparative survival analysis". European Journal of Cardio-Thoracic Surgery. 23 (4): 461–466. doi:10.1016/S1010-7940(03)00024-1. ISSN 1010-7940.
- ↑ Roesel, Christian; Terjung, Sarah; Weinreich, Gerhard; Hager, Thomas; Chalvatzoulis, Eleftherios; Metzenmacher, Martin; Welter, Stefan (2016). "Sarcomatoid carcinoma of the lung: a rare histological subtype of non-small cell lung cancer with a poor prognosis even at earlier tumour stages". Interactive CardioVascular and Thoracic Surgery: ivw392. doi:10.1093/icvts/ivw392. ISSN 1569-9293.